Stemming the Rising Tide of New Viral Hepatitis Infections Globally
Nov
16
2024
Convention Center: Room 29
11:00 AM - 12:30 PM
Captured
World Class Speakers
Description
Prevention of new infections is key to achieving the goal of global HBV and HCV elimination. Experts in this session discuss HBV and HCV epidemiology; challenges and potential solutions to reducing infections globally; and the respective roles of policy, harm reduction, improved diagnostics, and innovation in treatment/vaccination to address the key pillar of infection prevention in the overall approach to achieve HBV and HCV elimination.Presentations
11:00 AM - 11:15 AM
Nov
16
2024
San Diego, CA
Report Card on Incident Hepatitis B and Hepatitis C Infections and Primary Drivers of New Infections by Country
John W Ward, MD, Presenter
DEI
Hepatitis
11:15 AM - 11:30 AM
Nov
16
2024
San Diego, CA
Innovative Strategies for Hepatitis B and Hepatitis C Prevention and Care for People Who Inject Drugs and Incarcerated Persons
Jason Grebely, PhD, Presenter
DEI
Hepatitis
11:30 AM - 11:45 AM
Nov
16
2024
San Diego, CA
Expanding Treatment as Prevention for Hepatitis B and Hepatitis C
Jordan J. Feld, MD, MPH, FAASLD, Presenter
DEI
Hepatitis
11:45 AM - 12:00 PM
Nov
16
2024
San Diego, CA
Vaccine-Based Strategies for Hepatitis B and Hepatitis C
Rania Tohme, MD, MPH, Presenter
DEI
Hepatitis
12:00 PM - 12:20 PM
Nov
16
2024
San Diego, CA
Panel Discussion
Norah Terrault, MD, MPH, FAASLD, Moderator
DEI
Hepatitis
Objectives
- Summarize the unique challenges in the prevention of new HBV and HCV infections.
- Identify successful strategies to reduce new HBV and HCV infections using antiviral therapy combined with harm reduction.
- Review remaining gaps in HBV vaccination.
- Discuss progress regarding HCV vaccine development.